Skip to Content

Nitisinone Pregnancy and Breastfeeding Warnings

Nitisinone is also known as: Nityr, Orfadin

Nitisinone Pregnancy Warnings

Animal studies have shown incomplete skeletal ossification of fetal bones (at 0.4 to 20 times the recommended human dose), increased gestational length (at 4 to 20 times the recommended human dose), and decreased offspring survival (at 0.4 times the recommended human dose). In addition, reduced litter size, decreased birth weight, and decreased survival after birth was observed in animals receiving 12 times the recommended clinical dose based on relative body surface area. There are no controlled data in human pregnancy. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

FDA pregnancy category: C Potential benefit should outweigh the potential risk.

See references

Nitisinone Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.

Animals exposed to nitisinone in breast milk showed signs of ocular toxicity and decreased body weight.

See references

References for pregnancy information

  1. "Product Information. Orfadin (nitisinone)." Orphan Pharmaceuticals USA, Inc, Nashville, TN.

References for breastfeeding information

  1. "Product Information. Orfadin (nitisinone)." Orphan Pharmaceuticals USA, Inc, Nashville, TN.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.